CBAT

CBAK Energy Technology, Inc.

There isn't enough reported data to score CBAT yet.

VRT

Vertiv Holdings Co

87
Fundamentals85/ 100
Valuation87/ 100
Upside potential86/ 100
Risk potential19/ 100

VRT's fundamentals are strong and it looks cheap: trading at 39x earnings, about half its usual 72x. Analysts expect strong earnings growth.

CBAT Fundamentals

MetricStatus
Strong
Weak
Strong
Weak

CBAT's revenue and cash flow are currently strong, but its profitability and balance sheet are weak.

VRT Fundamentals

MetricStatus
Strong
Strong
Strong
Strong

VRT's revenue, profitability, cash flow and balance sheet are all currently strong.

CBAT PE Valuation

CBAT has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 4.8x next year's earnings.

VRT PE Valuation

CHEAPFAIREXPENSIVE39x77x116x155x
CHEAPFAIREXPENSIVE39x77x116x155x
LevelPEPriceVs current
Forward23x$210—
Current39x$210—
Cheap58x$308+47%
Fair72x$383+83%
Expensive88x$472+125%

Historical ranges are pointers, not guarantees.

VRT's PE is in its cheap range at 39x. If earnings grow as analysts expect, today's price would be 23x next year's earnings.

CBAT Forward outlook

MetricOutlook
--
Returning to profit
Strong growth
Strongly improving
Limited
High

Analysts expect CBAT to return to profit, with revenue growing.

VRT Forward outlook

MetricOutlook
Strongly improving
Strong growth
Strong growth
Strongly improving
Moderate
Moderate

Analysts expect strong earnings and revenue growth for VRT, with profitability improving.

CBAT Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $0.96 on Nov 12.

There is not enough scenario data to compare CBAT and VRT's risk to reward.

VRT Risk to reward

ScenarioChangePrice
Upside+122%$466.33
Downside-19%$169.11

Calculated from the latest close: $209.64 on Nov 12.

There is not enough scenario data to compare CBAT and VRT's risk to reward.

CBAT Earnings Per Share

Q2 2023: $-0.17Q3 2023: $-0.10Q4 2023: $-0.03Q1 2024: $0.10Q2 2024: $0.20Q3 2024: $0.13Q4 2024: $0.13Q1 2025: $0.00Q2 2025: $-0.10Q3 2025: $-0.07Q4 2025: $-0.10Q1 2026: $-0.18Forward: $0.20
Q2 2023: $-0.17Q3 2023: $-0.10Q4 2023: $-0.03Q1 2024: $0.10Q2 2024: $0.20Q3 2024: $0.13Q4 2024: $0.13Q1 2025: $0.00Q2 2025: $-0.10Q3 2025: $-0.07Q4 2025: $-0.10Q1 2026: $-0.18Forward: $0.20
QuarterTTM EPSYoY
Forward$0.20—
Q1 2026-$0.18-$0.18
Q4 2025-$0.10-177%
Q3 2025-$0.07-154%
Q2 2025-$0.10-150%
Q1 2025$0.00-100%
Q4 2024$0.13+$0.16
Q3 2024$0.13+$0.23
Q2 2024$0.20+$0.37

CBAT is still losing money, but less than at its worst: $0.18 per share over the past year, against $0.35 at its worst in late 2019.

VRT Earnings Per Share

Q4 2023: $1.19Q1 2024: $1.05Q2 2024: $1.29Q3 2024: $1.51Q4 2024: $1.28Q1 2025: $1.72Q2 2025: $2.09Q3 2025: $2.65Q4 2025: $3.41Q1 2026: $3.98Q2 2026: $4.42Q3 2026: $5.35Forward: $9.14
Q4 2023: $1.19Q1 2024: $1.05Q2 2024: $1.29Q3 2024: $1.51Q4 2024: $1.28Q1 2025: $1.72Q2 2025: $2.09Q3 2025: $2.65Q4 2025: $3.41Q1 2026: $3.98Q2 2026: $4.42Q3 2026: $5.35Forward: $9.14
QuarterTTM EPSYoY
Forward$9.14+71%
Q3 2026$5.35+102%
Q2 2026$4.42+111%
Q1 2026$3.98+131%
Q4 2025$3.41+166%
Q3 2025$2.65+75%
Q2 2025$2.09+62%
Q1 2025$1.72+64%
Q4 2024$1.28+7.6%

VRT's earnings per share have climbed steadily: $5.35 over the past year, up 102% from the year before, and higher year over year every quarter since late 2021.

CBAT Quarterly Revenue

Q2 2023: $42MQ3 2023: $63MQ4 2023: $56MQ1 2024: $59MQ2 2024: $48MQ3 2024: $45MQ4 2024: $25MQ1 2025: $35MQ2 2025: $41MQ3 2025: $61MQ4 2025: $59MQ1 2026: $70M
Q2 2023: $42MQ3 2023: $63MQ4 2023: $56MQ1 2024: $59MQ2 2024: $48MQ3 2024: $45MQ4 2024: $25MQ1 2025: $35MQ2 2025: $41MQ3 2025: $61MQ4 2025: $59MQ1 2026: $70M
QuarterRevenueYoY
Q1 2026$69.6M+99%
Q4 2025$58.8M+132%
Q3 2025$60.9M+37%
Q2 2025$40.5M-15%
Q1 2025$34.9M-41%
Q4 2024$25.4M-55%
Q3 2024$44.6M-30%
Q2 2024$47.8M+13%

CBAT has the stronger quarterly revenue trend. Revenue is up 99% for CBAT versus up 61% for VRT.

VRT Quarterly Revenue

Q4 2023: $1.9BQ1 2024: $1.6BQ2 2024: $2BQ3 2024: $2.1BQ4 2024: $2.3BQ1 2025: $2BQ2 2025: $2.6BQ3 2025: $2.7BQ4 2025: $2.9BQ1 2026: $2.6BQ2 2026: $3.3BQ3 2026: $4.3B
Q4 2023: $1.9BQ1 2024: $1.6BQ2 2024: $2BQ3 2024: $2.1BQ4 2024: $2.3BQ1 2025: $2BQ2 2025: $2.6BQ3 2025: $2.7BQ4 2025: $2.9BQ1 2026: $2.6BQ2 2026: $3.3BQ3 2026: $4.3B
QuarterRevenueYoY
Q3 2026$4.3B+61%
Q2 2026$3.3B+24%
Q1 2026$2.6B+30%
Q4 2025$2.9B+23%
Q3 2025$2.7B+29%
Q2 2025$2.6B+35%
Q1 2025$2B+24%
Q4 2024$2.3B+26%

VRT's revenue has grown year over year every quarter since late 2020: $4.3B last quarter, up 61% from the same quarter a year ago.

CBAT Free Cash Flow

Q2 2023: --Q3 2023: −$449,524Q4 2023: $20MQ1 2024: −$454,011Q2 2024: $3MQ3 2024: $17MQ4 2024: $4MQ1 2025: −$22MQ2 2025: $4MQ3 2025: $6MQ4 2025: $16MQ1 2026: $11M
Q2 2023: --Q3 2023: −$449,524Q4 2023: $20MQ1 2024: −$454,011Q2 2024: $3MQ3 2024: $17MQ4 2024: $4MQ1 2025: −$22MQ2 2025: $4MQ3 2025: $6MQ4 2025: $16MQ1 2026: $11M
QuarterFree cash flowYoY
Q1 2026$10.5M+$32.8M
Q4 2025$16.1M+310%
Q3 2025$6M-64%
Q2 2025$4.1M+65%
Q1 2025-$22.3M-$21.9M
Q4 2024$3.9M-80%
Q3 2024$16.5M+$17M
Q1 2024-$454K-105%

CBAT has the stronger cash trend. Its trailing FCF is up 6,165% versus its history, compared with VRT at up 337%.

VRT Free Cash Flow

Q4 2023: $308MQ1 2024: $102MQ2 2024: $344MQ3 2024: $342MQ4 2024: $365MQ1 2025: $267MQ2 2025: $278MQ3 2025: $464MQ4 2025: $886MQ1 2026: $654MQ2 2026: $927MQ3 2026: $655M
Q4 2023: $308MQ1 2024: $102MQ2 2024: $344MQ3 2024: $342MQ4 2024: $365MQ1 2025: $267MQ2 2025: $278MQ3 2025: $464MQ4 2025: $886MQ1 2026: $654MQ2 2026: $927MQ3 2026: $655M
QuarterFree cash flowYoY
Q3 2026$654.9M+41%
Q2 2026$926.5M+233%
Q1 2026$654.2M+145%
Q4 2025$885.6M+143%
Q3 2025$463.5M+36%
Q2 2025$277.9M-19%
Q1 2025$266.8M+162%
Q4 2024$364.5M+18%

VRT generated $3.1B in free cash flow over the past year, up 127% from the year before.

CBAT Total Shares

Q2 2023: 89MQ3 2023: 90MQ4 2023: 89MQ1 2024: 90MQ2 2024: 90MQ3 2024: 90MQ4 2024: 90MQ1 2025: 90MQ2 2025: 90MQ3 2025: 90MQ4 2025: 89MQ1 2026: 89M
Q2 2023: 89MQ3 2023: 90MQ4 2023: 89MQ1 2024: 90MQ2 2024: 90MQ3 2024: 90MQ4 2024: 90MQ1 2025: 90MQ2 2025: 90MQ3 2025: 90MQ4 2025: 89MQ1 2026: 89M
PeriodChange %Net change
Quarterly0%--
1 year-0.8%-692K shares
3 years+0.3%+234K shares
5 years+5.1%+4.3M shares
Available history+152%+53.9M shares

CBAT has the edge over VRT on shareholder dilution, with a more favorable share count trend.

VRT Total Shares

Q4 2023: 386MQ1 2024: 379MQ2 2024: 384MQ3 2024: 384MQ4 2024: 386MQ1 2025: 390MQ2 2025: 390MQ3 2025: 391MQ4 2025: 391MQ1 2026: 392MQ2 2026: 393MQ3 2026: 393M
Q4 2023: 386MQ1 2024: 379MQ2 2024: 384MQ3 2024: 384MQ4 2024: 386MQ1 2025: 390MQ2 2025: 390MQ3 2025: 391MQ4 2025: 391MQ1 2026: 392MQ2 2026: 393MQ3 2026: 393M
PeriodChange %Net change
Quarterly0%-64.9K shares
1 year+0.4%+1.8M shares
3 years+1.1%+4.4M shares
5 years+10%+36M shares
Available history+63%+152M shares

VRT has 393M diluted shares, about the same as a year ago.

CBAT Net Leverage

Q4 2023: -1.8xQ1 2024: 1.2xQ2 2024: -0.3xQ3 2024: 2.9xQ4 2024: 3.6xQ1 2025: 8.4x
Q4 2023: -1.8xQ1 2024: 1.2xQ2 2024: -0.3xQ3 2024: 2.9xQ4 2024: 3.6xQ1 2025: 8.4x
QuarterNet LeverageStatus
Q1 20258.4xHigh
Q4 20243.6xElevated
Q3 20242.9xModerate
Q2 2024-0.3xNet Cash
Q1 20241.2xHealthy
Q4 2023-1.8xNet Cash

CBAT's net debt is about 8.4 years of its operating earnings (EBITDA), up from 1.2 years a year ago.

VRT Net Leverage

Q4 2023: 1.9xQ1 2024: 2.2xQ2 2024: 1.8xQ3 2024: 1.4xQ4 2024: 1.0xQ1 2025: 0.8xQ2 2025: 0.7xQ3 2025: 0.8xQ4 2025: 0.6xQ1 2026: 0.3xQ2 2026: 0.1xQ3 2026: -0.2x
Q4 2023: 1.9xQ1 2024: 2.2xQ2 2024: 1.8xQ3 2024: 1.4xQ4 2024: 1.0xQ1 2025: 0.8xQ2 2025: 0.7xQ3 2025: 0.8xQ4 2025: 0.6xQ1 2026: 0.3xQ2 2026: 0.1xQ3 2026: -0.2x
QuarterNet LeverageStatus
Q3 2026-0.2xNet Cash
Q2 20260.1xVery low
Q1 20260.3xVery low
Q4 20250.6xVery low
Q3 20250.8xVery low
Q2 20250.7xVery low
Q1 20250.8xVery low
Q4 20241.0xHealthy

VRT has more cash than debt.

CBAT Weekly Momentum

MetricValueStatus
RSI51.5Neutral
Stochastic48.3Neutral

CBAT's weekly RSI is 52 (neutral) and its Stochastic is 48 (neutral).

VRT Weekly Momentum

MetricValueStatus
RSI43.0Neutral
Stochastic26.4Neutral

VRT's weekly RSI is 43 (neutral) and its Stochastic is 26 (neutral).

CBAT PE vs Industrials Sector

MetricCBATSector medianRelative
PEN/A24x—

CBAT has no meaningful PE right now: it lost money over the past year.

VRT PE vs Industrials Sector

MetricVRTSector medianRelative
PE39x24x63% above
PE %35855 pts below

VRT is trading at 39x earnings, a 63% premium to the Industrials sector's median of 24x.

CBAT Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$1.0811% below
20 week MA$0.889.1% above
50 week MA$0.8513% above
100 week MA$0.897.9% above
200 week MA$0.971% below

CBAT has the edge over VRT on trend strength, trading above more of its moving averages.

VRT Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$221.85.5% below
20 week MA$254.418% below
50 week MA$253.917% below
100 week MA$189.111% above
200 week MA$123.570% above

VRT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 70% above its 200-week average.

CBAT Yearly ROI

YearStart priceEnd priceROI
2020$1.14$6.26+449%
2021$6.26$1.69-73%
2022$1.69$0.98-42%
2023$0.98$1.05+7.1%
2024$1.05$1.07+1.9%
2025$1.07$0.86-20%
2026 YTD$0.86$0.96+12%

CBAT's yearly returns have swung widely, from +449% in 2020 to −73% in 2021. It's up 12% so far in 2026.

VRT Yearly ROI

YearStart priceEnd priceROI
2020$10.9$18.9+73%
2021$18.9$24.9+31%
2022$24.9$12.8-48%
2023$12.8$48.0+275%
2024$48.0$115.1+140%
2025$115.1$167.6+46%
2026 YTD$167.6$209.6+25%

VRT has the edge over CBAT on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key